Is Now The Time To Buy Stock In Novavax, Palantir, AMC Or Facebook?

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.

Here’s the latest news and updates for Novavax, Palantir, AMC and Facebook Monday morning.

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Friday morning after the company reported final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain in a pivotal Phase 3 trial in the United Kingdom of NVX–CoV2373.

Faurecia will use Palantir's Foundry software to gain further insight into its data across the company, from manufacturing to purchasing, from engineering to finances.

Palantir Foundry was designed to help organizations integrate disparate data sources and make the best possible use of their data.

See Also: How To Buy Palantir Stock

Facebook, Inc. (NASDAQ:FB) has nearly 10,000 people working in its group developing augmented and virtual reality devices.

The headcount suggests that almost one-fifth of Facebook’s global workforce is working at the company’s Reality Labs division, as per The Verge, citing internal organizational data.

See also: How to Buy AMC Stock

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.